Anticancer Effects of I-BET151, an Inhibitor of Bromodomain and Extra-Terminal Domain Proteins

I-BET151 is an inhibitor of bromodomain and extra-terminal domain (BET) proteins that selectively inhibits BET family members (BRD2, BRD3, BRD4, and BRDT). Over the past ten years, many studies have demonstrated the potential of I-BET151 in cancer treatment. Specifically, I-BET151 causes cell cycle...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Jiacheng, Liu, Ziqiang, Zhao, Yulei, Ma, Chengyuan, Huang, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443787/
https://www.ncbi.nlm.nih.gov/pubmed/34540687
http://dx.doi.org/10.3389/fonc.2021.716830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443787/
https://www.ncbi.nlm.nih.gov/pubmed/34540687
http://dx.doi.org/10.3389/fonc.2021.716830

Ejemplares similares